Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B : a randomized trial
-
- ENOMOTO Masaru
- Department of Hepatology, Graduate School of Medicine, Osaka City University Medical School
-
- TAMORI Akihiro
- Department of Hepatology, Graduate School of Medicine, Osaka City University Medical School
-
- TOYAMA KOHMOTO Madoka
- Department of Hepatology, Graduate School of Medicine, Osaka City University Medical School
-
- HAYASHI Takehiro
- Department of Hepatology, Graduate School of Medicine, Osaka City University Medical School
-
- MORIKAWA Hiroyasu
- Department of Hepatology, Graduate School of Medicine, Osaka City University Medical School
-
- JOMURA Hisato
- Department of Hepatology, Graduate School of Medicine, Osaka City University Medical School
-
- SAKAGUCHI Hiroki
- Department of Hepatology, Graduate School of Medicine, Osaka City University Medical School
-
- HABU Daiki
- Department of Hepatology, Graduate School of Medicine, Osaka City University Medical School
-
- KAWADA Norifumi
- Department of Hepatology, Graduate School of Medicine, Osaka City University Medical School
-
- SHIOMI Susumu
- Department of Nuclear Medicine, Graduate School of Medicine, Osaka City University Medical School
-
- NISHIGUCHI Shuhei
- Department of Internal Medicine, Hyogo College of Medicine
この論文をさがす
収録刊行物
-
- Hepatology research : the official journal of the Japan Society of Hepatology
-
Hepatology research : the official journal of the Japan Society of Hepatology 38 (9), 954-959, 2008-09-01
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1573105975437854080
-
- NII論文ID
- 10021946661
-
- NII書誌ID
- AA11140867
-
- ISSN
- 13866346
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles